OHSU study: CAR-T therapy shows long-term survival for patients with lymphoma
Credit: OHSU News
Richard Maziarz, M.D., leader of the immune effector cellular therapy program at the OHSU Knight Cancer Institute, co-led clinical trials confirming long-term survival for lymphoma patients treated with FDA-approved CAR-T cell therapy. (OHSU)